LEXICON PHARMACEUTICALS, INC. LXRX
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2000-04-07
LEXICON PHARMACEUTICALS, INC. statistics & valuation
Market cap$1.1B
P / S22.7×
P / B10.5×
Net margin-101.1%
Return on equity-46.8%
FCF margin-136.2%
Net debt$15.1M
Enterprise value USD$1.1B
Earnings yield EBIT/EV-4.3%
Return on capital-29.8%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -98.2% | -634.2% | -14265.0% | -72489.2% | -29224.8% | -199.2% | 43.9% | -163.4% | -142.5% | -160.5% |
| Net margin | -101.1% | -644.8% | -14710.9% | -73341.0% | -29449.0% | -244.1% | 40.4% | -190.7% | -134.1% | -165.8% |
| FCF margin | -136.2% | -578.5% | -13485.6% | -64875.5% | -29610.1% | -596.2% | 35.3% | -235.3% | -202.4% | -221.9% |
| Return on assets | -27.2% | -67.2% | -77.2% | -52.5% | -64.1% | -28.7% | 31.2% | -42.4% | -28.2% | -27.6% |
| Return on equity | -46.8% | -137.3% | -190.2% | -87.0% | -77.3% | -37.5% | 111.1% | 456.5% | -180.2% | -78.5% |
| Debt / equity | 0.46× | 0.69× | 1.07× | 0.41× | 0.00× | 0.00× | 2.12× | -9.46× | 3.69× | 0.61× |
| Current ratio | 4.88 | 5.44 | 5.60 | 6.08 | 4.02 | 3.37 | 5.17 | 4.72 | 3.05 | 2.17 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.